Murtuza Rampurwala to Treatment Outcome
This is a "connection" page, showing publications Murtuza Rampurwala has written about Treatment Outcome.
Connection Strength
0.228
-
Phase 1b study of orteronel in postmenopausal women with hormone-receptor positive (HR+) metastatic breast cancer. Invest New Drugs. 2017 02; 35(1):87-94.
Score: 0.060
-
Role of the androgen receptor in triple-negative breast cancer. Clin Adv Hematol Oncol. 2016 Mar; 14(3):186-93.
Score: 0.057
-
Delayed hepatic metastasis from a benign fibroblastic meningioma thirty-one years after surgical resection of the intracranial tumor. J Clin Oncol. 2011 Mar 20; 29(9):e214-5.
Score: 0.040
-
Selective left anterior descending shunting provides effective off-pump myocardial protection. Ann Thorac Surg. 2010 Jan; 89(1):24-9.
Score: 0.037
-
Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic Disease. Cancer Discov. 2021 02; 11(2):308-325.
Score: 0.020
-
Phase I Study of an AKT Inhibitor (MK-2206) Combined with Lapatinib in Adult Solid Tumors Followed by Dose Expansion in Advanced HER2+ Breast Cancer. Clin Cancer Res. 2016 06 01; 22(11):2659-67.
Score: 0.014